Corrigendum: Progesterone receptor modulates ERα action in breast cancer.
Mohammed, Hisham; Russell, I Alasdair; Stark, Rory; Rueda, Oscar M; Hickey, Theresa E; Tarulli, Gerard A; Serandour, Aurelien A; Birrell, Stephen N; Bruna, Alejandra; Saadi, Amel; Menon, Suraj; Hadfield, James; Pugh, Michelle; Raj, Ganesh V; Brown, Gordon D; D'Santos, Clive; Robinson, Jessica L L; Silva, Grace; Launchbury, Rosalind; Perou, Charles M; Stingl, John; Caldas, Carlos; Tilley, Wayne D; Carroll, Jason S.
; 526(7571): 144, 2015 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-26245370
Progesterone receptor modulates ERα action in breast cancer.
STAT1 facilitates oestrogen receptor α transcription and stimulates breast cancer cell proliferation.
IQGAP1 binds to estrogen receptor-α and modulates its function.
Significance of estrogen receptor subtypes in breast tumorigenesis and progression.
Biomedical research in france and brazil: an analysis of significant differences and ethical issues
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
Emerging significance of estrogen cancer coregulator signaling in breast cancer.
SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.
Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability.